Impact of incident myocardial infarction on the risk of venous thromboembolism: the TromsO Study

被引:49
作者
Rinde, L. B. [1 ]
Lind, C. [1 ]
Smabrekke, B. [1 ]
Njolstad, I. [1 ,2 ]
Mathiesen, E. B. [1 ,3 ]
Wilsgaard, T. [2 ]
Lochen, M. -L. [2 ]
Hald, E. M. [1 ,4 ]
Vik, A. [1 ,4 ]
Braekkan, S. K. [1 ,4 ]
Hansen, J. -B. [1 ,4 ]
机构
[1] Univ Tromso, KG Jebsen Thrombosis Res & Expertise Ctr TREC, Dept Clin Med, N-9037 Tromso, Norway
[2] Univ Tromso, Dept Community Med, Epidemiol Chron Dis Res Grp, N-9037 Tromso, Norway
[3] Univ Tromso, Dept Clin Med, Brain & Circulat Res Grp, N-9037 Tromso, Norway
[4] Univ Hosp North Norway, Div Internal Med, Tromso, Norway
关键词
epidemiology; myocardial infarction; pulmonary embolism; risk factors; venous thromboembolism; ACUTE CORONARY SYNDROMES; SUBCLINICAL ATHEROSCLEROSIS; ANTIPLATELET THERAPY; PULMONARY-EMBOLISM; UNSTABLE ANGINA; FAMILY-HISTORY; DOUBLE-BLIND; ARTERIAL; POPULATION; THROMBOSIS;
D O I
10.1111/jth.13329
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Recent studies have demonstrated an association between venous thromboembolism (VTE) and arterial thrombotic diseases. Objectives To study the association between incident myocardial infarction (MI) and VTE in a prospective population-based cohort. Methods Study participants (n=29506) were recruited from three surveys of the TromsO Study (conducted in 1994-1995, 2001-2002, and 2007-2008) and followed up to 2010. All incident MI and VTE events during follow-up were recorded. Cox regression models with age as the time scale and MI as a time-dependent variable were used to calculate hazard ratios (HRs) of VTE adjusted for sex, body mass index, blood pressure, diabetes mellitus, HDL cholesterol, smoking, physical activity, and education level. Results During a median follow-up of 15.7years, 1853 participants experienced an MI and 699 experienced a VTE. MI was associated with a 51% increased risk of VTE (HR1.51; 95% confidence interval [CI]1.08-2.10) and a 72% increased risk of pulmonary embolism (PE) (HR1.72; 95%CI1.07-2.75), but not significantly associated with the risk of deep vein thrombosis (DVT) (HR1.36; 95%CI0.86-2.15). The highest risk estimates for PE were observed during the first 6months after the MI (HR8.49; 95%CI4.00-18.77). MI explained 6.2% of the PEs in the population (population attributable risk) and 78.5% of the PE risk in MI patients (attributable risk). Conclusions Our findings indicate that MI is associated with a transient increased VTE risk, independently of traditional atherosclerotic risk factors. The risk estimates were particularly high for PE.
引用
收藏
页码:1183 / 1191
页数:9
相关论文
共 41 条
[1]   Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].
Alexander, John H. ;
Becker, Richard C. ;
Bhatt, Deepak L. ;
Cools, Frank ;
Crea, Filippo ;
Dellborg, Mikael ;
Fox, Keith A. A. ;
Goodman, Shaun G. ;
Harrington, Robert A. ;
Huber, Kurt ;
Husted, Steen ;
Lewis, Basil S. ;
Lopez-Sendon, Jose ;
Mohan, Puneet ;
Montalescot, Gilles ;
Ruda, Mikhail ;
Ruzyllo, Witold ;
Verheugt, Freek ;
Wallentin, Lars ;
Darius, Harald ;
Simoons, Maarten ;
Boersma, Eric ;
DeLemos, James ;
Spencer, Fred .
CIRCULATION, 2009, 119 (22) :2877-U39
[2]   Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis [J].
Bank, I ;
Libourel, EJ ;
Middeldorp, S ;
Hamulyák, K ;
van Pampus, ECM ;
Koopman, MMW ;
Prins, MH ;
van der Meer, J ;
Büller, HR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :79-84
[3]   Are myocardial infarction and venous thromboembolism associated? Population-based case-control and cohort studies [J].
Barsoum, Michel K. ;
Cohoon, Kevin P. ;
Roger, Veronique L. ;
Mehta, Ramila A. ;
Hodge, David O. ;
Bailey, Kent R. ;
Heit, John A. .
THROMBOSIS RESEARCH, 2014, 134 (03) :593-598
[4]   Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromso study [J].
Braekkan, S. K. ;
Mathiesen, E. B. ;
Njolstad, I. ;
Wilsgaard, T. ;
Stormer, J. ;
Hansen, J. B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) :1851-1857
[5]   Competing Risk of Atherosclerotic Risk Factors for Arterial and Venous Thrombosis in a General Population: The Tromso Study [J].
Braekkan, Sigrid K. ;
Hald, Erin M. ;
Mathiesen, Ellisiv B. ;
Njolstad, Inger ;
Wilsgaard, Tom ;
Rosendaal, Frits R. ;
Hansen, John-Bjarne .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) :487-491
[6]   Body Height and Risk of Venous Thromboembolism [J].
Braekkan, Sigrid K. ;
Borch, Knut H. ;
Mathiesen, Ellisiv B. ;
Njolstad, Inger ;
Wilsgaard, Tom ;
Hansen, John-Bjarne .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (10) :1109-1115
[7]  
Collins R, 1996, BMJ-BRIT MED J, V313, P652
[8]   Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and YII [J].
Doggen, Carine J. M. ;
Rosendaal, Frits R. ;
Meijers, Joost C. M. .
BLOOD, 2006, 108 (13) :4045-4051
[9]   Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis:: a population study based on 23 796 consecutive autopsies [J].
Eliasson, A. ;
Bergqvist, D. ;
Bjorck, M. ;
Acosta, S. ;
Sternby, N. H. ;
Ogren, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) :1897-1902
[10]   Atrial fibrillation and future risk of venous thromboembolism: the Tromso study [J].
Enga, K. F. ;
Rye-Holmboe, I. ;
Hald, E. M. ;
Lochen, M. -L. ;
Mathiesen, E. B. ;
Njolstad, I. ;
Wilsgaard, T. ;
Braekkan, S. K. ;
Hansen, J. -B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (01) :10-16